Bevacizumab: Improved survival at what cost?

Jill M. Kolesar

Research output: Contribution to journal › Editorial

7 Scopus citations

Original language	English
Pages (from-to)	1017
Number of pages	1
Journal	American Journal of Health-System Pharmacy
Volume	62
Issue number	10
DOIs	https://doi.org/10.1093/ajhp/62.10.1017
State	Published - May 15 2005

ASJC Scopus subject areas

This output contributes to the following UN Sustainable Development Goals (SDGs)

TY - JOUR

T1 - Bevacizumab

T2 - Improved survival at what cost?

AU - Kolesar, Jill M.

PY - 2005/5/15

Y1 - 2005/5/15

UR - http://www.scopus.com/inward/record.url?scp=18744383046&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=18744383046&partnerID=8YFLogxK

U2 - 10.1093/ajhp/62.10.1017

DO - 10.1093/ajhp/62.10.1017

M3 - Editorial

C2 - 15901584

AN - SCOPUS:18744383046

SN - 1079-2082

VL - 62

SP - 1017

JO - American Journal of Health-System Pharmacy

JF - American Journal of Health-System Pharmacy

IS - 10

ER -